Roger Luo

2.7k total citations
30 papers, 1.3k citations indexed

About

Roger Luo is a scholar working on Hematology, Molecular Biology and Surgery. According to data from OpenAlex, Roger Luo has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 14 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Roger Luo's work include Acute Myeloid Leukemia Research (10 papers), RNA Interference and Gene Delivery (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Roger Luo is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), RNA Interference and Gene Delivery (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Roger Luo collaborates with scholars based in United States, China and United Kingdom. Roger Luo's co-authors include Michael J. Thirman, Paul Polak, Federico Simone, Joseph J. Kaberlein, Catherine Lavau, Changchun Du, Francis Y. Lee, Neil P. Shah, Marjolein L. Donker and Yibin Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Roger Luo

30 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Roger Luo 694 510 229 220 185 30 1.3k
Tobias Berg 856 1.2× 402 0.8× 231 1.0× 160 0.7× 52 0.3× 60 1.3k
S. Tiong Ong 1.1k 1.5× 501 1.0× 357 1.6× 196 0.9× 152 0.8× 56 1.8k
Sébastien Malinge 631 0.9× 611 1.2× 308 1.3× 190 0.9× 85 0.5× 33 1.4k
Abhishek Niroula 653 0.9× 640 1.3× 462 2.0× 143 0.7× 82 0.4× 45 1.5k
Andrea Hoelbl‐Kovacic 481 0.7× 474 0.9× 345 1.5× 306 1.4× 105 0.6× 24 1.2k
Cezary Swider 522 0.8× 494 1.0× 201 0.9× 175 0.8× 79 0.4× 20 1.1k
Yosuke Minami 802 1.2× 812 1.6× 355 1.6× 287 1.3× 108 0.6× 103 1.6k
Lara Tickenbrock 1.0k 1.5× 715 1.4× 330 1.4× 189 0.9× 42 0.2× 28 1.5k
Mirosław Majewski 522 0.8× 308 0.6× 279 1.2× 292 1.3× 195 1.1× 28 1.4k

Countries citing papers authored by Roger Luo

Since Specialization
Citations

This map shows the geographic impact of Roger Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Luo more than expected).

Fields of papers citing papers by Roger Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Luo. The network helps show where Roger Luo may publish in the future.

Co-authorship network of co-authors of Roger Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Luo. A scholar is included among the top collaborators of Roger Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Luo. Roger Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarda, Sujata P., et al.. (2024). Real-World Healthcare Resource Utilization, Healthcare Costs, and Injurious Falls Among Elderly Patients with Geographic Atrophy. Clinical ophthalmology. Volume 18. 3215–3226. 1 indexed citations
2.
Luo, Roger, et al.. (2020). Prevalence of Lumbosacral Transitional Vertebrae in Patients With Symptomatic Femoroacetabular Impingement Requiring Hip Arthroscopy. Arthroscopy The Journal of Arthroscopic and Related Surgery. 37(1). 149–155. 12 indexed citations
3.
Walker, Mark S., et al.. (2018). Pretreatment costs of care and time to initial treatment for patients with cancer of unknown primary. Journal of Comparative Effectiveness Research. 7(6). 523–533. 3 indexed citations
4.
Liou, Kevin, et al.. (2016). Drug-eluting Balloon Versus Second Generation Drug Eluting Stents in the Treatment of In-stent Restenosis: A Systematic Review and Meta-analysis. Heart Lung and Circulation. 25(12). 1184–1194. 14 indexed citations
5.
6.
7.
Li, Bingjie, Joseph J. Kaberlein, Roger Luo, et al.. (2013). Regulation of MEIS1 by distal enhancer elements in acute leukemia. Leukemia. 28(1). 138–146. 15 indexed citations
8.
Qian, Zhijian, Hung–Hsiang Yu, Roger Luo, et al.. (2009). Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo. Leukemia. 23(9). 1650–1657. 26 indexed citations
9.
Chen, Jing, Donna A. Santillan, Wei Wei, et al.. (2008). Loss of MLL PHD Finger 3 Is Necessary for MLL-ENL–Induced Hematopoietic Stem Cell Immortalization. Cancer Research. 68(15). 6199–6207. 45 indexed citations
10.
11.
Christopher, Lisa J., Donghui Cui, Chi‐Yuan Wu, et al.. (2008). Metabolism and Disposition of Dasatinib after Oral Administration to Humans. Drug Metabolism and Disposition. 36(7). 1357–1364. 158 indexed citations
12.
Alexander, Jessy J., Anthony Chang, Bradley K. Hack, et al.. (2006). Distinct and Separable Roles of the Complement System in Factor H-Deficient Bone Marrow Chimeric Mice with Immune Complex Disease. Journal of the American Society of Nephrology. 17(5). 1354–1361. 22 indexed citations
13.
Shah, Neil P., Francis Y. Lee, Roger Luo, et al.. (2006). Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis. Blood. 108(1). 286–291. 207 indexed citations
14.
Lee, Francis Y., Louis J. Lombardo, Amy Camuso, et al.. (2005). BMS-354825 potently inhibits multiple selected oncogenic tyrosine kinases and possesses broad-spectrum antitumor activities in vitro and in vivo. Cancer Research. 65. 159–159. 38 indexed citations
15.
Lee, Francis Y., Mei-Li Wen, Rajeev S. Bhide, et al.. (2005). Dasatinib (BMS-354825) Overcomes Multiple Mechanisms of Imatinib Resistance in Chronic Myeloid Leukemia (CML).. Blood. 106(11). 1994–1994. 14 indexed citations
16.
17.
Lee, Francis Y., Louis J. Lombardo, R. M. Borzilleri, et al.. (2004). Pharmacodynamic analysis of target inhibition and tumor endothelial cell death in biopsies obtained from patients treated with the VEGF receptor antagonists SU5416 or SU6668. Cancer Research. 64. 921–921. 3 indexed citations
18.
Giorgino, Toni, et al.. (2004). Cognitive Human Factors for Telemedicine Systems. Studies in health technology and informatics. 107(Pt 2). 974–8. 5 indexed citations
19.
Polak, Paul, Federico Simone, Joseph J. Kaberlein, Roger Luo, & Michael J. Thirman. (2003). ELL and EAF1 are Cajal Body Components That Are Disrupted in MLL-ELL Leukemia. Molecular Biology of the Cell. 14(4). 1517–1528. 37 indexed citations
20.
Luo, Roger, Catherine Lavau, Changchun Du, et al.. (2001). The Elongation Domain of ELL Is Dispensable but Its ELL-Associated Factor 1 Interaction Domain Is Essential for MLL-ELL-Induced Leukemogenesis. Molecular and Cellular Biology. 21(16). 5678–5687. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tobias Berg Breakdown of academic impact, for papers by S. Tiong Ong Breakdown of academic impact, for papers by Sébastien Malinge Breakdown of academic impact, for papers by Abhishek Niroula Breakdown of academic impact, for papers by Andrea Hoelbl‐Kovacic Breakdown of academic impact, for papers by Cezary Swider Breakdown of academic impact, for papers by Yosuke Minami Breakdown of academic impact, for papers by Lara Tickenbrock Breakdown of academic impact, for papers by Mirosław Majewski
Rankless by CCL
2026